Reporting owner · Q3 2026 · CIK 1750050

Sukhatme Mayukh: insider trades.

Sukhatme Mayukh reported 15 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 7 sales ($36.5M), across 1 company.

Transactions
15
Purchases (P)
0
Sales (S)
7
Companies
1
Name as filed
Sukhatme Mayukh

Companies

CompanyRelationshipTransactions
Roivant Sciences Ltd. (ROIV)Director, Officer · President & CIO15

Transactions

15 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-08-21Roivant Sciences Ltd.S144,756$36.4818,630,739Form 4
2026-08-21Roivant Sciences Ltd.M144,756$3.8518,775,495Form 4
2026-08-20Roivant Sciences Ltd.S17,519$37.318,630,739Form 4
2026-08-20Roivant Sciences Ltd.M17,519$3.8518,648,258Form 4
2026-08-19Roivant Sciences Ltd.S172,899$37.1718,630,739Form 4
2026-08-19Roivant Sciences Ltd.M172,899$3.8518,803,638Form 4
2026-08-18Roivant Sciences Ltd.M105,141$3.8518,735,880Form 4
2026-08-18Roivant Sciences Ltd.S105,141$36.5918,630,739Form 4
2026-08-18Roivant Sciences Ltd.M31,801$3.8518,662,540Form 4
2026-08-18Roivant Sciences Ltd.S31,801$37.1818,630,739Form 4
2026-08-17Roivant Sciences Ltd.M284,707$3.8518,915,446Form 4
2026-08-17Roivant Sciences Ltd.S284,707$36.2518,630,739Form 4
2026-08-14Roivant Sciences Ltd.S243,177$36.2318,630,739Form 4
2026-08-14Roivant Sciences Ltd.M243,177$3.8518,873,916Form 4
2026-06-30Roivant Sciences Ltd.F46,878$35.3918,630,739Form 4

Questions

What stock did Sukhatme Mayukh buy or sell?

Sukhatme Mayukh reported 15 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 7 sales ($36.5M), across 1 company.

Is Sukhatme Mayukh the same person as other filers with this name?

This page covers SEC CIK 1750050 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/sukhatme-mayukh-1750050.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.